擅長領域：淋巴瘤、頭頸腫瘤的化學治療及靶向治療?

執(zhí)業(yè)經(jīng)歷： 姓名：夏奕 職稱：副主任醫(yī)師, 碩士生導師 專長：淋巴瘤、頭頸腫瘤的化學治療及靶向治療出診時間及診室：周二下午，周四下午，314診室學術兼職　　廣東省腫瘤靶向與個體化治療青委會常委　　廣東省女醫(yī)師協(xié)會淋巴瘤專委會常委個人簡介　　2009年獲得中山大學腫瘤學博士學位，常年從事淋巴瘤及頭頸腫瘤的內(nèi)科治療，具有豐富的臨床經(jīng)驗。以第一/共同第一作者發(fā)表SCI收錄論文十余篇，主持國家自然科學青年基金、廣東省科學技術研究基金各一項 。代表性文章、成果（1）. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Zheng Li,Yi Xia, Li-Na Feng,et al. Lancet Oncology,2016, Sep;17(9):1240-1247.（2）. High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma. Zhang Xi, Huang Jia-Jia, Xia Yi, et al. Oncotarget. 2016 Jun 7;7(23):35404-35411.（3）. Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma. Bi Xi-wen, Xia Yi, Zhang Wen-wen, et al. Annals of Hematology, 2015 May;94(5):1175-1184.（4）. Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma. Zhu Ying-jie, Sun Yue-Li, Xia Yi, et al. Medical Oncology, 2012 Jun;29(2):1127-1133.(5).《癌癥知多少》之《淋巴瘤》主編。 詳細介紹